[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $cmps

Oppenheimer upgrades Compass Pathways to Outperform with a $XX target, citing conviction that COMP360 psilocybin therapy could be the first FDA-approved psychedelic treatment for depression. Recent social posts highlight significant call option buying and positive sentiment around the company's development.

### About $cmps
Compass Pathways is a biotechnology company focused on developing psilocybin-based therapies for mental health.  

### Insights
- $cmps engagements is up XXXXX% from the previous week.
- $cmps posts created is up XX% from the previous week.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +38%  
X Month: XXXXXXX +31%  
X Months: XXXXXXXXX +19%  
X Year: XXXXXXXXX +77%  
1-Year High: XXXXXXX on 2025-06-23  
1-Year Low: XXX on 2025-10-26  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +201%  
X Year: XXXXX +302%  
1-Year High: XXX on 2025-06-24  
1-Year Low: X on 2025-12-07  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $cmps in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +423%  
X Year: XXXXX +188%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-12-07  

The most influential creators that mention $cmps in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)       | X    | XXXXX     | X     | XXXXX       |
| [@salmaogs](/creator/twitter/salmaogs)             | X    | XXXXXX    | X     | XXX         |
| [@Yam_Trades](/creator/twitter/Yam_Trades)         | X    | XXXXX     | X     | XXX         |
| [@PsychedVantage](/creator/twitter/PsychedVantage) | X    | XXXXX     | X     | XXX         |
| [@flobrand](/creator/twitter/flobrand)             | X    | XXXXX     | X     | XXX         |
| [@seedytx19](/creator/twitter/seedytx19)           | X    | XXXXX     | X     | XX          |
| [@Brad_E_Schulz](/creator/twitter/Brad_E_Schulz)   | X    | XXXXXX    | X     | X           |

[View More](/list/creators/$cmps/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% +20%  
X Months: XXX% +22%  
X Year: XXX% +13%  
1-Year High: XXX% on 2024-12-23  
1-Year Low: XX% on 2025-03-31  

Most Supportive Themes:
- CYBN CYB003 Phase X Data: (30%) Cybin's CYB003 Phase X trial data shows promising efficacy for depression treatment, boosting investor confidence and highlighting the potential of psychedelic medicines.
- Psychedelic Sector Growth: (25%) The psychedelic sector is experiencing increased investor interest and institutional attention, driven by positive trial data and the potential for revolutionary mental health treatments.
- Compass Pathways R&D Collaboration: (15%) Compass Pathways is entering into R&D collaborations to pioneer precision treatments for various conditions, indicating advancements in their therapeutic development.
  
Most Critical Themes:
  

### Top $cmps Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"pre market gainer of 12/10 $ABVX $GEV $STOK $MRVI $SATS $GPCR $PLAB $CMPS $GLUE $NMR $DRTS $HSBC $TERN $TEVA $WAT $LBRT $FMST $RZLT $PUMP"  
[X Link](https://x.com/StockxSignal/status/1998754576636457007) [@StockxSignal](/creator/x/StockxSignal) 2025-12-10T14:00Z 2794 followers, XXX engagements


"Upgrades 12/10: $ABBV $ANDE $CMC $CMPS $DCBO $DYN $FNV $GEV $HP $HSBC $JBTM $LBRT $MIDD $OWL $PEP $PNR $PSN $PUMP $SATS $TEX $VALE $WAT $WPM . Downgrades 12/10: $AEM $BIIB $EMR $FER $LAKE $NE $PTEN $RACE $RCI $RIG $RRX $VLTO $VTMX"  
[X Link](https://x.com/OpenOutcrier/status/1998753455268368747) [@OpenOutcrier](/creator/x/OpenOutcrier) 2025-12-10T13:55Z 79.9K followers, 1757 engagements


"$CMPS +3% Oppenheimer upgrades Compass Pathways to Outperform with a $XX target citing rising conviction that COMP360 psilocybin therapy could become the first FDA-approved psychedelic treatment for depression"  
[X Link](https://x.com/notreload_ai/status/1998717060336201803) [@notreload_ai](/creator/x/notreload_ai) 2025-12-10T11:30Z 3057 followers, XXX engagements


"12/09 Flow Highlights For anyone who tracked 12/5 $BRZE playing out on earnings ( $CMP was a dud) & $PLAY calls look ok so far. Flow Multiples $SGML 10.39x Bullish Premium $PLAY 9.67x Bullish Premium $GFS 6.38x Bullish Premium $ESTA 5.2x Bullish Premium $CRMD 3.9x BUllish Premium RR/IRR $MLYS January Sell 1500x30P / Buy 1500x45C (Biotech) $CRMD March Sell 437x10P / Buy 437x13C (Anti-Bacterial Dialysis treatment) $GH January Sell 654x80P / Buy 654x125C $CORZ Feb Sell 500x15P / Buy 500x20C $TAC August Sell 831x35C / Sell 831x13P / Buy 831x10P / Buy 831x20C (1000 in total) $JNJ 12/26 Sell"  
[X Link](https://x.com/Yam_Trades/status/1998510266624127392) [@Yam_Trades](/creator/x/Yam_Trades) 2025-12-09T21:49Z 5197 followers, 2669 engagements